India’s COVID-19 tally inched closer to the 90-lakh mark with 45,576 confirmed cases on Thursday, according to the Union Ministry of Health and Family Welfare.
The country’s Covid-19 tally has risen to 89,58,484 including 83,83,602 recoveries and 4,43,303 active cases. With 585 new deaths, the cumulative count mounted to 1,31,578.
This is the twelfth consecutive day when India reported less than 50,000 cases in a day. The last time daily new cases crossed the 50,000-threshold was on November 7.
The new recoveries continue to overtake the daily new cases continuously since the past 47 days. India’s active caseload has fallen under the five per cent mark today, according to an official press release.
Table of Contents
Here are the LIVE updates on Coronavirus Cases:
The Telangana High Court on Thursday directed the state government to conduct 50,000 coronavirus tests every day and if need be increase the number to 1 lakh in the wake of second wave of the pandemic that is being experienced in the national capital.
A bench headed by Chief Justice Raghvendra Singh Chauhan while hearing a batch of PILs on COVID-19 related issues noted that if more tests were conducted the virus can be contained and directed the state government to carry out 50,000 tests daily and expected that the number may go up to 1 lakh in a day.
The bench was informed by the Advocate General that the state government was already conducting around 50,000 COVID-19 tests per day.
Meghalaya reported 109 fresh COVID-19 cases, pushing the tally to 10,979, a senior health
official said on Thursday.
The death count rose to 104 after one more patient succumbed to the virus, Health Services Director Aman War said.
He said 60 patients have recovered from the disease since Wednesday, increasing the number of those cured to 10,074 in the state.
An emergency use authorization request for the Covid-19 vaccine developed by Pfizer and BioNTech was expected to be filed with the FDA on Friday, the US government and BioNTech’s co-founder said.
This type of Food and Drug Administration authorization is temporary or conditional and is granted in response to an emergency situation such as a pandemic.
“Pfizer’s partner BioNTech has announced that tomorrow they intend to file for emergency use authorization at the FDA,” health secretary Alex Azar told a press conference Thursday in Washington.
BioNTech co-founder Ugur Sahin earlier told AFP in a Zoom interview: “The documents will be finalized today and tomorrow and submitted to the FDA.”
The FDA did not say how long it would take to review the data on vaccine efficacy and safety, the two main criteria.
Andhra Pradesh reported 1,316 new cases of COVID-19 taking the tally of total cases to 8,58,711, said state government on Thursday.
According to state government, total recoveries in the state stand at 8,35,801 with 1,821 people recovered in last 24 hours.
The death count reached 6,911 in the state with eleven people succumbed to the disease. Out of the eleven deaths reported today, two people each succumbed in Chittoor and Krishna district while one death each reported in Anantapur, East Godavari, Guntur, Nellore, Srikakulam, Visakhapatnam and West Godavari districts.
US President-elect Joe Biden said Thursday he would not order a nationwide shutdown to fight the Covid-19 pandemic despite a surge in cases.
States and cities have been imposing their own restrictions, including home confinement, the closure of indoor dining and a limit on gatherings as infections soar across the country.
“There’s no circumstance which I can see that would require total national shutdown. I think that would be counterproductive,” Biden, who takes office on January 20, told reporters.
He said however that rules for when and how businesses and other establishments can open would have to be calibrated based on the threat in the area in question, noting the varying levels of spread throughout the country.
The anti-viral drug remdesivir should not be used to treat Covid-19 patients no matter how severe their illness as it has “no important effect” on survival chances, the World Health Organization said Friday.
Scratching one of the few treatments that had shown some initial promise in severe patients, a WHO Guideline Development Group (GDG) of international experts said there was “no evidence based on currently available data that it does improve patient-important outcomes”.
The United States, the European Union and other countries have granted temporary approval for the use of remdesivir after initial research showed it may shorten recovery time in some coronavirus patients.